Evaluation of the effects of nerve growth factor and anti-nerve growth factor on the development of central catecholamine-containing neurons

Richard J. Konkol, Richard Mailman, Elizabeth G. Bendeich, A. Marcine Garrison, Robert A. Mueller, George R. Breese

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Intracisternal NGF or anti-NGF has been found to produce no long-term major alterations in central norepinephrine (NE) or dopamine levels when administered to neonatal rats. While NGF and anti-NGF were found to produce significant changes in brain NE content within one week of treatment, changes in central NE were no longer detectable at 30 days of age. Modification of the growth response of the central adrenergic neurons following 6-OHDA treatment was also not affected by NGF or anti-NGF when evaluated 3 weeks after treatment. However, centrally administered anti-NGF did induce a loss of peripheral NE terminals, which was attributed to leakage of the anti-NGF from the central injection site.

Original languageEnglish (US)
Pages (from-to)277-285
Number of pages9
JournalBrain Research
Volume144
Issue number2
DOIs
StatePublished - Apr 14 1978

Fingerprint

Nerve Growth Factor
Catecholamines
Neurons
Norepinephrine
Adrenergic Neurons
Oxidopamine
Dopamine
Therapeutics
Injections
Brain
Growth

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)
  • Molecular Biology
  • Clinical Neurology
  • Developmental Biology

Cite this

Konkol, Richard J. ; Mailman, Richard ; Bendeich, Elizabeth G. ; Garrison, A. Marcine ; Mueller, Robert A. ; Breese, George R. / Evaluation of the effects of nerve growth factor and anti-nerve growth factor on the development of central catecholamine-containing neurons. In: Brain Research. 1978 ; Vol. 144, No. 2. pp. 277-285.
@article{48df1385644745f2b50d4b0c96bb0ff6,
title = "Evaluation of the effects of nerve growth factor and anti-nerve growth factor on the development of central catecholamine-containing neurons",
abstract = "Intracisternal NGF or anti-NGF has been found to produce no long-term major alterations in central norepinephrine (NE) or dopamine levels when administered to neonatal rats. While NGF and anti-NGF were found to produce significant changes in brain NE content within one week of treatment, changes in central NE were no longer detectable at 30 days of age. Modification of the growth response of the central adrenergic neurons following 6-OHDA treatment was also not affected by NGF or anti-NGF when evaluated 3 weeks after treatment. However, centrally administered anti-NGF did induce a loss of peripheral NE terminals, which was attributed to leakage of the anti-NGF from the central injection site.",
author = "Konkol, {Richard J.} and Richard Mailman and Bendeich, {Elizabeth G.} and Garrison, {A. Marcine} and Mueller, {Robert A.} and Breese, {George R.}",
year = "1978",
month = "4",
day = "14",
doi = "10.1016/0006-8993(78)90154-3",
language = "English (US)",
volume = "144",
pages = "277--285",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "2",

}

Evaluation of the effects of nerve growth factor and anti-nerve growth factor on the development of central catecholamine-containing neurons. / Konkol, Richard J.; Mailman, Richard; Bendeich, Elizabeth G.; Garrison, A. Marcine; Mueller, Robert A.; Breese, George R.

In: Brain Research, Vol. 144, No. 2, 14.04.1978, p. 277-285.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Evaluation of the effects of nerve growth factor and anti-nerve growth factor on the development of central catecholamine-containing neurons

AU - Konkol, Richard J.

AU - Mailman, Richard

AU - Bendeich, Elizabeth G.

AU - Garrison, A. Marcine

AU - Mueller, Robert A.

AU - Breese, George R.

PY - 1978/4/14

Y1 - 1978/4/14

N2 - Intracisternal NGF or anti-NGF has been found to produce no long-term major alterations in central norepinephrine (NE) or dopamine levels when administered to neonatal rats. While NGF and anti-NGF were found to produce significant changes in brain NE content within one week of treatment, changes in central NE were no longer detectable at 30 days of age. Modification of the growth response of the central adrenergic neurons following 6-OHDA treatment was also not affected by NGF or anti-NGF when evaluated 3 weeks after treatment. However, centrally administered anti-NGF did induce a loss of peripheral NE terminals, which was attributed to leakage of the anti-NGF from the central injection site.

AB - Intracisternal NGF or anti-NGF has been found to produce no long-term major alterations in central norepinephrine (NE) or dopamine levels when administered to neonatal rats. While NGF and anti-NGF were found to produce significant changes in brain NE content within one week of treatment, changes in central NE were no longer detectable at 30 days of age. Modification of the growth response of the central adrenergic neurons following 6-OHDA treatment was also not affected by NGF or anti-NGF when evaluated 3 weeks after treatment. However, centrally administered anti-NGF did induce a loss of peripheral NE terminals, which was attributed to leakage of the anti-NGF from the central injection site.

UR - http://www.scopus.com/inward/record.url?scp=0017836986&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017836986&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(78)90154-3

DO - 10.1016/0006-8993(78)90154-3

M3 - Article

VL - 144

SP - 277

EP - 285

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 2

ER -